- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01286506
Observational Study of Blood Pressure Measurements and Continuous Dialysis
Observational Study Evaluating the Hemodynamic Relationship Between Volume Removal and Pulse Pressure Variation During Renal Replacement Therapy
Dialysis is used to control the fluid balance and metabolic state of patients with kidney disease. Control of the metabolic state, via electrolytes, can be monitored using labs that are routinely drawn from patients undergoing continuous hemodialysis. Control of fluid removal is much more difficult. This study aims to determine whether changes in the blood pressure associated with breathing correlate with or predict intolerance to fluid responsiveness with continuous dialysis.
We hypothesize that a measurement of changes in blood pressure with breathing called arterial pulse pressure variation may be able to predict the ability to remove fluid during continuous renal replacement therapy.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- The University of Chicago Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- age > 17 years old
- CVVHD renal replacement therapy
- indwelling arterial line
Exclusion Criteria:
- age < 18 years old
- pregnancy
- temperature < 34°C
- severe mechanical ventilator dyssynchrony
- cardiac arrhythmias precluding automated PPV measurement by ICU monitors
- non-pulsatile cardiac flow
- open thoracic cavity
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Mechanically ventilated patients
|
|
Non-mechanically ventilated patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Predictive value of pulse pressure variation for tolerance of fluid removal on CVVHD
Time Frame: Iterative 24 hr periods for the duration of CRRT
|
Iterative 24 hr periods for the duration of CRRT
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Increased doses of vasoactive agents on CRRT
Time Frame: Iterative 24 hr periods for the duration of CRRT
|
Iterative 24 hr periods for the duration of CRRT
|
|
Inability to meet goal ultrafiltration rate
Time Frame: Iterative 24 hr periods for the duration of CRRT
|
Iterative 24 hr periods for the duration of CRRT
|
|
Hypotensive events on CRRT
Time Frame: Iterative 24 hr periods for the duration of CRRT
|
Iterative 24 hr periods for the duration of CRRT
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael O'Connor, MD, University of Chicago
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16710A
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shock
-
Assistance Publique - Hôpitaux de ParisTraumabase Group; Capgemini Invent; Ecole polytechnique; EHESS (Ecole des hautes... and other collaboratorsCompletedWounds and Injuries | Hemorrhagic Shock | Traumatic ShockFrance
-
Biomedizinische Forschungs gmbHMedical University of ViennaCompletedSepsis | Toxic-Shock Syndrome
-
King's College Hospital NHS TrustUniversity Hospital BirminghamCompletedTraumatic Haemorrhagic ShockUnited Kingdom
-
Haukeland University HospitalMinistry of Defence, NorwayCompletedHemorrhagic Shock | Hypovolemic ShockNorway
-
Massachusetts General HospitalBeth Israel Deaconess Medical Center; Boston Medical Center; Tufts Medical Center and other collaboratorsRecruiting
-
Jason SperryNational Heart, Lung, and Blood Institute (NHLBI)TerminatedHemorrhagic ShockUnited States
-
University of Texas Southwestern Medical CenterUniversity of Washington; Resuscitation Outcomes ConsortiumCompletedHemorrhagic ShockUnited States
-
Ramathibodi HospitalUnknownSeptic Shock | Refractory ShockThailand
-
Arsenal Medical, Inc.RecruitingTrauma | Hemorrhagic Shock | Exsanguinating Hemorrhage | Shock; TraumaticUnited States
-
German Center for Neurodegenerative Diseases (DZNE)University Hospital, BonnUnknownSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockGermany